By registering for IMAP, you agree to our Terms of Use and acknowledge our Data Protection Notice. Your personal data will be processed in accordance with GDPR and used solely for the purposes of administering your access to investigational medicines through our Early Access Programs.
We collect and process your professional information, institutional details, and patient access requests to ensure regulatory compliance and safe distribution of medicines. Your data will be shared with quality managers, supply chain teams, and relevant sponsors as necessary for order processing.
You have the right to access, rectify, or delete your personal data at any time by contacting our Data Protection Officer.